Concepts (73)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Anna Gil's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Anna Gil has written about over time.
CytomegalovirusCytomegalovirus VaccinesVaccines, DNAT-LymphocytesVaccinationViral VaccinesVirus DiseasesAgingImmunity, HeterologousInfluenza, HumanImmunologic MemoryInfluenza A virusMajor Histocompatibility ComplexReceptors, Antigen, T-CellCD8-Positive T-LymphocytesImmunodominant EpitopesReceptors, Antigen, T-Cell, alpha-betaHerpesvirus 4, HumanRecombination, GeneticEpstein-Barr Virus Infections
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Cytomegalovirus | 1 | 2013 | 2013 | July 2013 |
Cytomegalovirus Vaccines | 1 | 2013 | 2013 | July 2013 |
Vaccines, DNA | 1 | 2013 | 2013 | July 2013 |
T-Lymphocytes | 2 | 2013 | 2015 | April 2014 |
Vaccination | 1 | 2015 | 2015 | January 2015 |
Viral Vaccines | 1 | 2015 | 2015 | January 2015 |
Virus Diseases | 1 | 2015 | 2015 | January 2015 |
Aging | 1 | 2015 | 2015 | January 2015 |
Immunity, Heterologous | 2 | 2015 | 2017 | June 2016 |
Influenza, Human | 2 | 2015 | 2017 | June 2016 |
Immunologic Memory | 3 | 2015 | 2021 | December 2017 |
Influenza A virus | 4 | 2015 | 2023 | May 2018 |
Major Histocompatibility Complex | 2 | 2017 | 2020 | September 2018 |
Receptors, Antigen, T-Cell | 4 | 2017 | 2023 | December 2018 |
CD8-Positive T-Lymphocytes | 8 | 2015 | 2023 | December 2018 |
Immunodominant Epitopes | 3 | 2017 | 2020 | February 2019 |
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2015 | 2023 | July 2019 |
Herpesvirus 4, Human | 5 | 2017 | 2023 | September 2019 |
Recombination, Genetic | 1 | 2020 | 2020 | March 2020 |
Epstein-Barr Virus Infections | 2 | 2019 | 2023 | July 2021 |
To return to the timeline,
click here.